Épidémiologie et facteurs de risque des tumeurs de la voie excrétrice urinaire supérieure : revue de la littérature pour le rapport annuel de l’Association française d’urologie

Ouzzane, A.; Rouprêt, Morgan; Leon, P.; Yates, David R.; Colin, P.

doi:10.1016/j.purol.2014.06.012

Cited by 36 publications

(18 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The decoction of plants is the etiologic agent found in our observation and could be the source of our sporadic cases. A risk factor similar to those found in the Balkan nephropathy and Chinese herbs recognized and reported in the literature since 1950 [3]. The discovery of TVES is happy chance in 10 to 16% of cases depending on the series with the waning of abdominal imaging performed for another reason [5].…”

Section: Tumors Of Upper Tract (Tves)supporting

confidence: 74%

“…The incidence of TVES peak between 70 and 80 years with an average age of diagnosis is between 65-70 years [3]. The young age of discovery in our case is explained by the youth of our population.…”

Section: Tumors Of Upper Tract (Tves)mentioning

confidence: 51%

“…Our case is a circumstance of discovery rarely reported in the literature and demonstrates advanced or metastatic TVES [6]. Other more specific functional signs are indicative of these tumors such as hematuria (68-82%), pain (20-30%) or lumbar mass (10%) [3]. According to the recommendation of the AFU and the UAE (grade C), the USSR (flexible ureterorenoscopy) allows both to make the diagnosis (biopsy, cytology in situ) and conservative treatment of TVES in a time [7].…”

Section: Tumors Of Upper Tract (Tves)mentioning

confidence: 56%

“…The young age of discovery in our case is explained by the youth of our population. They most commonly affect men with a sex ratio of 1.5 to 2, 8en Europe and the United State between the period of 1997 to 2010 [3,4]. Our observation is the first case reported in Madagascar and no similar study is found in the Malagasy literature where the incidence of TVES unknown in our country.…”

Section: Tumors Of Upper Tract (Tves)mentioning

confidence: 68%

“…The TVES entities are rare and account for about 5% of urothelial carcinomas all reported worldwide [3]. The incidence of TVES peak between 70 and 80 years with an average age of diagnosis is between 65-70 years [3].…”

Section: Tumors Of Upper Tract (Tves)mentioning

confidence: 99%

See 4 more Smart Citations

A Pseudo-Mesothelioma Pleural Revelant an Carcinoma Urothelial Metastatic: About a Case and Review of the Literature

NNM¹

2017

JLPRR

View full text Add to dashboard Cite

The authors illustrate through an observation of an aggressive and exceptional pleural evolution metastatic of a carcinoma urothelial of the upper urinary tract at the origin of an atypical radiological aspect and rarely described of pseudo-mesothelioma. In our case, the instillation with the BCG Pasteur by the percutaneous nephrostomy and the pleur X with the profit of a heavy chemotherapy enabled us to in fact circumvent the evolution towards the acute complications related to this pathology, the malignant pleuresis.Keywords: BCG; Chemotherapy; Differential diagnosis; Mesothelioma; Radiotherapy; Surgery; Urothelial carcinomaThe authors describe here the first Malagasy case of urothelial carcinoma of the upper urinary tract radiological discovery late in pleural metastatic and discuss differential diagnoses of the image and the evolution of this tumor treated with topical agent adjuvant through review of recent literature. ObservationMr RAV. 53 years old, no smoking was hospitalized for progressive worsening of dyspnea lasting for 6 months, accompanied by chest pain basi-left. In the interview we noted a notion regularly taking a decoction of clinical médicinales. L'examen virtues plants entering found an alteration of the general status (PS = 3 according to WHO), a left pulmonary syndrome without condensation fever. Radiography of thorax face showed pleural thickening picture left scalloped. Chest CT (Figure 1) confirmed the pleural lesions secondary look and abdominopelvic CT scan for staging (Figure 2) found a retroperitoneal mass compatible of renal tumor primitive right. Biologically, there was a LDH assay was raised to 1423 IU/ml (5 times normal). Histological examination of a biopsy transthoracic puncture confirmed the location of a secondary urothelial carcinoma at the pleura (pT4N2M1) (Figure 3). Our patient had received a course of BCG instillation Pasteur by percutaneous nephrostomy and the tear-X (thoracic drainage system) and died after three months of decline following the natural evolution of the tumor.

show abstract

Section: Tumors Of Upper Tract (Tves)supporting

confidence: 74%

Section: Tumors Of Upper Tract (Tves)mentioning

confidence: 51%

Section: Tumors Of Upper Tract (Tves)mentioning

confidence: 56%

Section: Tumors Of Upper Tract (Tves)mentioning

confidence: 68%

Section: Tumors Of Upper Tract (Tves)mentioning

confidence: 99%

See 3 more Smart Citations

A Pseudo-Mesothelioma Pleural Revelant an Carcinoma Urothelial Metastatic: About a Case and Review of the Literature

NNM¹

2017

JLPRR

View full text Add to dashboard Cite

show abstract

The prognostic value of CSN6 expression in upper tract urothelial carcinomas

Jhan

Lee

et al. 2019

The Kaohsiung J of Med Scie

View full text Add to dashboard Cite

CSN6 is a subunit of the constitutive photomorphogenesis 9 (COP9) signalosome (CSN). CSN is involved in cellular and developmental processes such as signal transduction, transcriptional activation, cell cycle control, and tumorigenesis. CSN6 is highly expressed in several human cancers, including colorectal cancer, and breast cancer. However, no previous research has elaborated on the relationship between CSN6 expression and survival in patients with upper tract urothelial carcinoma (UTUC). Therefore, the purpose of this study is to evaluate the clinical significance of CSN6 in UTUC. CSN6 expression in 89 patients with UTUC enrolled in this study was examined using immunohistochemistry. The associations between CSN6 expression and clinicopathological variables were analyzed. CSN6 expression was significantly correlated with patients with high pathological stage (P = .006), male gender (P = .025), and high serum creatinine levels (P = .014). In univariate and multivariable analysis, high CSN6 expression was associated with a higher bladder recurrence (P = .005) and poor cancer‐specific survival (P = .001) for UTUC. In conclusion, CSN6 expression is a potential biomarker for predicting cancer recurrence and clinical survival in UTUC. Further research is necessary to investigate its role in the progression of UTUC.

show abstract

Comparison of the risks of renal cell carcinoma or urothelial cancer between hemodialysis and peritoneal dialysis patients

Wang

Yen

et al. 2023

Int Urol Nephrol

View full text Add to dashboard Cite

Épidémiologie et facteurs de risque des tumeurs de la voie excrétrice urinaire supérieure : revue de la littérature pour le rapport annuel de l’Association française d’urologie

Cited by 36 publications

References 63 publications

A Pseudo-Mesothelioma Pleural Revelant an Carcinoma Urothelial Metastatic: About a Case and Review of the Literature

A Pseudo-Mesothelioma Pleural Revelant an Carcinoma Urothelial Metastatic: About a Case and Review of the Literature

The prognostic value of CSN6 expression in upper tract urothelial carcinomas

Comparison of the risks of renal cell carcinoma or urothelial cancer between hemodialysis and peritoneal dialysis patients

Contact Info

Product

Resources

About